Research / UI / Fundamental state Inspectable configuration
State dimensions Filing 0001511737-23-000037 General Corporate
Debt relative to revenue 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
238.11% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.48% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-35.43% · OPTIONAL · VALID
Revenue growth 85th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
27.85% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
162.39% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
41.17% · CORE · VALID
Operating margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
29.17% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
8.35% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.27% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 60 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 181.58%
Current 238.11%
Delta 56.52% Capex Intensity Decreased
Previous 0.97%
Current 0.48%
Delta -0.50% Cash Generation Decreased
Previous -8.03%
Current -35.43%
Delta -27.40% Growth Increased
Previous 14.37%
Current 27.85%
Delta 13.48% Inventory Pressure Increased
Previous 130.50%
Current 162.39%
Delta 31.89% Margin Increased
Previous 40.03%
Current 41.17%
Delta 1.15% Profitability Decreased
Previous 29.41%
Current 29.17%
Delta -0.24% R And D Intensity Increased
Previous 6.84%
Current 8.35%
Delta 1.51% Sbc Intensity Increased
Previous 0.22%
Current 0.27%
Delta 0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.